nicotinamide mononucleotide has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
| Borradaile, NM; Chan, P; Hughes-Large, JM; Pang, DK; Robson, DL; Toma, J | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Metabolic Syndrome
| Article | Year |
|---|---|
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity.
Topics: Animals; Aorta; Apoptosis; Cattle; Cell Death; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Drug Combinations; Endothelial Cells; Gene Expression Regulation; Humans; Immunohistochemistry; Laminin; Lipids; Metabolic Syndrome; Microcirculation; NAD; Niacin; Nicotinamide Mononucleotide; Obesity; Protein Binding; Proteoglycans; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; RNA Interference; RNA, Small Interfering; Serum Albumin | 2014 |